Seq_ID,Species,Phylogenetic lineage,Predicted drug resistance,Rifampicin,Isoniazid,Pyrazinamide,Ethambutol,Moxifloxacin,Amikacin,Cycloserine,Ethionamide,Kanamycin,Streptomycin,Capreomycin,Para-aminosalicylic acid,Clofazimine,Delamanid,Bedaquiline,Linezolid,Median genome coverage,Percentage reads mapped,Quality,Database version
T,Mycobacterium tuberculosis,Lineage 2,Pre-Extensive/Extensive drug-resistance predicted,rpoB_p.Leu452Pro (Low-level resistant|High),No mechanism identified,No mechanism identified,No mechanism identified,gyrA_p.Asp94Gly (Resistant|High),No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,252,99.11,Pass QC,tbtamr_2022-12-02
